APA (7th ed.) Citation

C, B., T, T., J, L., EP, H., ES, K., S, P., . . . PJ, N. (2021). First-in-man study to investigate safety, pharmacokinetics and exploratory pharmacodynamics of HTL0018318, a novel M1 -receptor partial agonist for the treatment of dementias. British journal of clinical pharmacology, 87(7), 2945. https://doi.org/10.1111/bcp.14710

Chicago Style (17th ed.) Citation

C, Bakker, et al. "First-in-man Study to Investigate Safety, Pharmacokinetics and Exploratory Pharmacodynamics of HTL0018318, a Novel M1 -receptor Partial Agonist for the Treatment of Dementias." British Journal of Clinical Pharmacology 87, no. 7 (2021): 2945. https://doi.org/10.1111/bcp.14710.

MLA (9th ed.) Citation

C, Bakker, et al. "First-in-man Study to Investigate Safety, Pharmacokinetics and Exploratory Pharmacodynamics of HTL0018318, a Novel M1 -receptor Partial Agonist for the Treatment of Dementias." British Journal of Clinical Pharmacology, vol. 87, no. 7, 2021, p. 2945, https://doi.org/10.1111/bcp.14710.